SK Hynix says its SSD subsidiary Solidigm has halted a review of a potential US IPO to fund a new US chip fab, citing "market conditions and share price trends"
THE SO WHAT
When a major memory player pauses an IPO meant to fund a US fab, it underlines how fragile the financing stack is for new capacity. If your roadmap assumes cheaper or more abundant NAND/SSD supply out of US fabs, extend your timelines and stress-test for tighter capex and slower ramps.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechReport: Dutch Spies Hacked Jared Kushner’s iPhone, Watched Him Use Sleazy Middle Eastern Slush Fund
State actors quietly reusing each other’s exploits against high-level political targets is a reminder that mobile devices are now persistent intelligence surfaces, not personal tools. For leadership teams handling sensitive negotiations or capital flows, assume phones are compromised and shift critical decision-making to hardened channels.
Deep & Emerging TechNearly 3,000 exploding stars challenge our understanding of the Universe
A dataset of 2,884 supernovae suggesting time-varying dark energy is a reminder that even “settled” models can flip when the sample size jumps. For teams leaning on scientific consensus in long-horizon bets — climate, space, fundamental physics — build strategies that can absorb paradigm shifts rather than assuming today’s model is final.
Deep & Emerging TechStartup Pursues Palmer Luckey’s Vision of Enhanced Military Dogs
$200M into genetically enhanced working dogs is another data point that defense is funding edge capabilities across biology, not just silicon. Dual-use founders should read this as validation that unconventional sensing and security platforms can get real capital if they map cleanly to mission outcomes.
Deep & Emerging TechCambridge scientists create a $10 chip that could put a medical lab on your wrist
A $10 optical sensor that matches lab precision and can monitor blood glucose and identify materials with 100% accuracy points to diagnostics moving from clinic to wrist. Healthcare operators and device makers should be planning for continuous, edge-based testing — and the data, reimbursement, and workflow changes that follow.